Gentile M., Specchia G., Derudas D., Galli M., Botta C., Rocco S., et al. (2021). Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials. HAEMATOLOGICA, 106(1), 291-294 [10.3324/haematol.2019.241513].

Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials

Botta C.;
2021-01-01

Gentile M., Specchia G., Derudas D., Galli M., Botta C., Rocco S., et al. (2021). Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials. HAEMATOLOGICA, 106(1), 291-294 [10.3324/haematol.2019.241513].
File in questo prodotto:
File Dimensione Formato  
106291.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 1.01 MB
Formato Adobe PDF
1.01 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/513541
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 12
social impact